索坦肾癌国人临床研究数据解读ppt课件.pptVIP

高血压作为索坦治疗晚期肾细胞癌的预测因子13 中位PFS (月) 0.0001 0.0001 PFS：有高血压 vs. 无高血压 (n=442) (n=92) (n=363) (n=171) 收缩压 舒张压 Brian I. Rini, Darrel P. Cohen, Dongrui R. et al. Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib. JNCI J Natl Cancer Inst (2011) doi: 10.1093/jnci/djr128 高血压作为索坦治疗晚期肾细胞癌的预测因子13 中位OS (月) P0.001 P0.001 收缩压 舒张压 OS：有高血压 vs. 无高血压 Brian I. Rini, Darrel P. Cohen, Dongrui R. et al. Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib. JNCI J Natl Cancer Inst (2011) doi: 10.10